BMI vs Body Fat: Which Matters for GLP-1?

BMI is the standard metric used for GLP-1 medication eligibility, but many patients and fitness professionals argue that body fat percentage is a better indicator of health. Both metrics have roles in GLP-1 treatment. This guide explains what each measures, their limitations, and which you should focus on during your weight loss journey.

What BMI Measures

BMI (Body Mass Index) is a simple calculation: weight in kilograms divided by height in meters squared. It categorizes weight status into underweight (under 18.5), normal (18.5-24.9), overweight (25-29.9), and obese (30+). BMI is used for GLP-1 eligibility because it is easy to calculate, standardized, and correlates with health outcomes at a population level.

BMI limitations: BMI does not distinguish between muscle and fat. A muscular person can have a "high" BMI without excess fat. Conversely, a person with normal BMI can have high body fat percentage (sometimes called "skinny fat" or metabolically obese normal weight). BMI also does not account for fat distribution, which matters because visceral (belly) fat is more dangerous than subcutaneous fat.

What Body Fat Percentage Measures

Body fat percentage directly measures the proportion of your body weight that is fat tissue. Healthy ranges are generally:

• Men: 10-20% (athletic to acceptable)
• Women: 18-28% (athletic to acceptable)
• Obese range: Men above 25%, women above 32%

Body fat percentage is a better indicator of metabolic health and cardiovascular risk than BMI alone. However, it is harder to measure accurately. Methods range from inexpensive but imprecise (bioimpedance scales) to accurate but expensive (DEXA scans, hydrostatic weighing).

For GLP-1 Eligibility: BMI Rules

Current FDA guidelines and clinical practice use BMI for GLP-1 medication eligibility. This means BMI 30+ qualifies without comorbidities, and BMI 27+ qualifies with comorbidities. Body fat percentage is not currently used as a formal eligibility criterion, even though it may be a more accurate health indicator.

If your BMI is below 27 but your body fat percentage is in the obese range, you may still have a case for treatment. Some providers consider the full clinical picture including body composition, metabolic markers, and health conditions when making prescribing decisions.

For Tracking Progress: Both Matter

During GLP-1 treatment, tracking both BMI/weight and body composition provides a more complete picture:

• Scale weight/BMI: Easy to track frequently; shows overall trajectory; the primary metric in clinical trials
• Body fat percentage: Reveals whether you are losing fat vs muscle; important for long-term health; check monthly or quarterly
• Waist circumference: Simple, free, and correlates well with visceral fat and metabolic health; check monthly

A common concern with GLP-1 medication is muscle loss. Tracking body fat percentage helps ensure you are losing primarily fat. If body fat percentage is not dropping proportionally with weight, it may indicate muscle loss, which should be addressed with protein intake and resistance training.

Practical Recommendations

• Use BMI for eligibility: It is the standard criterion; calculate yours to determine if you qualify for GLP-1 treatment
• Track waist circumference: Measure around your navel monthly; this is the easiest meaningful body composition metric
• Consider a DEXA scan: Before starting GLP-1 and every 3-6 months during treatment to track body composition changes
• Focus on muscle preservation: Regardless of which metric you prioritize, maintaining muscle through protein and exercise is essential

Getting Started

Whether you are tracking by BMI or body fat percentage, the first step is a provider consultation. Visit Trimi's treatment options page to get started. Compounded semaglutide is $99/month and tirzepatide is $125/month.

Frequently Asked Questions

Can I get GLP-1 if my BMI is normal but body fat is high?

Standard eligibility uses BMI, but if you have weight-related health conditions (prediabetes, hypertension, etc.) and your BMI is at least 27, you may qualify. Discuss your body composition and health markers with a Trimi provider during consultation.

Does GLP-1 cause muscle loss?

Some muscle loss occurs with any weight loss. Studies show approximately 25-40% of weight lost on GLP-1 may be lean mass. Adequate protein intake (1g per pound of target body weight) and resistance training can significantly reduce muscle loss during treatment.

Should I track BMI or body fat on GLP-1?

Track both if possible. Weight/BMI is easy and frequent. Body fat percentage and waist circumference provide important context about the quality of your weight loss. Together, they give the most complete picture of your progress.